NPI: 1184092116 · KISSIMMEE, FL 34747 · End-Stage Renal Disease (ESRD) Treatment Clinic/Center · NPI assigned 09/08/2015
Authorized official WEY, SAMUEL controls 20+ related entities in our dataset. Read more
| Authorized Official | WEY, SAMUEL (VP, LICENSURE & CERTIFICATION) |
| NPI Enumeration Date | 09/08/2015 |
Other providers sharing the same authorized official: WEY, SAMUEL
| Provider | City | State | Total Paid |
|---|---|---|---|
| DVA HEALTHCARE RENAL CARE INC | NORTH HOLLYWOOD | CA | $16.47M |
| DVA HEALTHCARE RENAL CARE INC | DELANO | CA | $16.43M |
| DVA RENAL HEALTHCARE INC | LOS ANGELES | CA | $15.51M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $14.93M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $13.67M |
| DVA RENAL HEALTHCARE INC | OAKLAND | CA | $13.42M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $13.25M |
| DVA HEALTHCARE RENAL CARE INC | YUMA | AZ | $12.88M |
| DVA HEALTHCARE RENAL CARE INC | BAKERSFIELD | CA | $12.77M |
| DVA RENAL HEALTHCARE INC | FULLERTON | CA | $12.19M |
| DVA HEALTHCARE RENAL CARE INC | POMONA | CA | $11.96M |
| DVA RENAL HEALTHCARE INC | ANAHEIM | CA | $11.32M |
| DVA RENAL HEALTHCARE INC | ESCONDIDO | CA | $10.94M |
| DVA HEALTHCARE RENAL CARE INC | COSTA MESA | CA | $10.08M |
| DVA HEALTHCARE RENAL CARE INC | INGLEWOOD | CA | $9.46M |
| DVA RENAL HEALTHCARE INC | VISALIA | CA | $9.22M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $8.83M |
| DVA HEALTHCARE RENAL CARE INC | BAKERSFIELD | CA | $8.56M |
| DVA HEALTHCARE RENAL CARE INC | INGLEWOOD | CA | $7.78M |
| DVA RENAL HEALTHCARE INC | PALM SPRINGS | CA | $7.48M |
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 1,446 | $448K |
| 2019 | 7,386 | $1.33M |
| 2020 | 9,478 | $853K |
| 2021 | 7,702 | $717K |
| 2022 | 5,363 | $1.14M |
| 2023 | 1,648 | $148K |
| 2024 | 168 | $11K |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 90999 | Unlisted dialysis procedure, inpatient or outpatient | 13,980 | 1,028 | $2.32M |
| Q4081 | Injection, epoetin alfa, 100 units (for esrd on dialysis) | 9,405 | 458 | $1.05M |
| J1270 | Injection, doxercalciferol, 1 mcg | 5,094 | 356 | $656K |
| A4657 | Syringe, with or without needle, each | 1,688 | 528 | $315K |
| J1756 | Injection, iron sucrose, 1 mg | 1,166 | 170 | $123K |
| 83970 | 344 | 181 | $34K | |
| 85041 | 319 | 181 | $33K | |
| 85048 | 295 | 167 | $29K | |
| 82728 | 297 | 168 | $27K | |
| 83540 | 269 | 152 | $24K | |
| 83550 | 269 | 152 | $24K | |
| G0499 | Hepatitis b screening in non-pregnant, high risk individual includes hepatitis b surface antigen (hbsag), antibodies to hbsag (anti-hbs) and antibodies to hepatitis b core antigen (anti-hbc), and is followed by a neutralizing confirmatory test, when performed, only for an initially reactive hbsag result | 26 | 14 | $3K |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | 19 | 12 | $3K |
| 82108 | 20 | 12 | $2K |